Daily Mail on MSN
New treatment for sleep apnea relieves deadly disorder without bulky breathing device
In a recent trial, 60 percent of patients using the device had fewer breathing interruptions and less daytime fatigue. For ...
Findings of a real-world study confirm guidelines that recommend physical therapy as first-line treatment; it has a slight edge over cognitive-behavioral therapy.
Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...
A randomized controlled trial evaluating the safety and efficacy of proximal hypoglossal nerve stimulation, or pHGNS, (an ...
Discusses Osteoporosis Treatment Landscape and Clinical Potential of EB613 Oral Tablet April 20, 2026 11:00 AM ...
Over a billion people in the world are living with some form of mental crisis, and the numbers aren't seeing a downward trend ...
TROP2 and PTEN Biomarkers May Predict Patient Response to Reqorsa® Gene TherapyREQORSA Induced Apoptosis and Decreased Tumor Volume in ALK-EML4 Positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results